NCT06522035View on ClinicalTrials.gov

Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis

PHASE1RecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

September 30, 2026

Conditions
Arthritis, Psoriatic
Interventions
DRUG

Allocetra

Intra-articular injecton of Allocetra into the target joint.

Trial Locations (4)

3109601

RECRUITING

Rambam Medical Center, Haifa

3436212

RECRUITING

Carmel Medical Center, Haifa

4428164

RECRUITING

Meir Medical Center, Kfar Saba

6423906

RECRUITING

Tel Aviv Sourasky Medical Center - Ichilov, Tel Aviv

Sponsors
All Listed Sponsors
lead

Enlivex Therapeutics Ltd.

INDUSTRY

NCT06522035 - Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis | Biotech Hunter | Biotech Hunter